Yakacki, Shandas receive CU Denver | Anschutz Medical Campus Technology Transfer Awards

Congratulations to Chris Yakacki, mechanical engineering, and Robin Shandas, bioengineering, for receiving CU Denver | Anschutz Technology Transfer Awards. Chris was awarded “New Inventor of the Year,” while EndoShape, Inc., a company based on work by Robin, was awarded the “CU Denver | Anschutz Company of the Year.”

The entire press release is below.

——————

CU Announces Denver, Anschutz Medical Campus Technology Transfer Awards

Researchers and companies working on improved medical devices and innovative diagnostic approaches are among those honored for technology commercialization.

AURORA (Jun. 3, 2014) – The University of Colorado Technology Transfer Office (TTO) presented awards yesterday to University of Colorado Denver and Anschutz Medical Campus researchers, companies and advisors who best represent both the spirit of innovation at CU and best practices in commercialization of university technologies.

In the last two decades, inventions by researchers from CU’s four campuses have led to the formation of 132 new companies. Of these, 89 have operations in Colorado, seven have “gone public,” becoming publicly traded companies (either through an IPO or via a reverse merger), and 18 have been acquired by public companies. In total, companies created based on CU technology have attracted over $6.2 billion in financing. Four FDA-approved drugs have resulted from CU innovations, positively impacting the lives of millions of patients.

“Year after year, CU faculty continue to impress by bringing clinically relevant innovations in the door, and successfully engaging advisors and entrepreneurs to bring those innovations to life,” said Rick Silva, senior director of technology transfer for CU Denver|Anschutz. “We are especially delighted that this year’s innovators are all positively and directly impacting patient care right now, by virtue of the use of their innovations in the clinic.”

The researchers and company recognized this year are developing innovative diagnostics and medical devices. This year’s award winners include:

Robert C. Doebele, Inventor of the Year, CU Denver|Anschutz. Doebele is an Associate Professor in the Division of Medical Oncology at the CU School of Medicine, and a physician at University of Colorado Hospital. His research focuses on oncogenic gene fusions in lung cancer, using molecular, cellular, genetic, and translational approaches to elucidate both the sensitivity and cellular resistance to oncogene-targeted therapy. Since 2012, Doebele has worked with TTO to commercialize two novel companion diagnostics to guide therapy for NSCLC patients, both of which are currently being licensed for development by a large molecular diagnostics company. [photo attached]

Yakacki (9-12)-WEBChristopher M. Yakacki,New Inventor of the Year, CU Denver|Anschutz. Yakacki is an Assistant Professor of Mechanical Engineering at CU’s Denver campus, where he runs the Smart Materials and Biomechanics (SMAB) Lab. Since joining CU’s faculty in 2012, he has fabricated a medical imaging accessory device to solve an unmet need brought to him by clinicians in interventional radiology, with a prototype device being used on patients within months of initial development; he has also worked with TTO on two subsequent ideas that have received positive early commercial feedback.

Steve VanNurden, Business Advisor of the Year. VanNurden is President and CEO of the Fitzsimons Redevelopment Authority. He came to Colorado in 2012 from the Mayo Clinic, where he had responsibilities ranging from the establishment of Mayoclinic.com, to managing a venture portfolio, to overseeing a technology licensing and commercialization enterprise. VanNurden’s experience in new enterprise formation, investing, and commercial development has been readily available and invaluable to TTO and to CU faculty members working towards commercializing CU research.

shandasEndoShape, CU Denver|Anschutz Company of the Year. EndoShape is a medical device company in the coil embolization and occlusion market. The company was founded based on shape memory polymer technology licensed from CU in 2007, from the laboratory of Robin Shandas, who remains on the board and executive team of EndoShape today. The company’s Medusa™ Vascular Plug product received 510(k) marketing clearance and will be commercially available in 2014, with the potential to positively impact the 50,000 U.S. patients who have peripheral vascular embolization procedures each year.

Awards to researchers and startups at other CU campuses were presented at separate campus events in April.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s